Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Impact of Antigen Density on the Binding Mechanism of IgG Antibodies.

Hadzhieva M, Pashov AD, Kaveri S, Lacroix-Desmazes S, Mouquet H, Dimitrov JD.

Sci Rep. 2017 Jun 19;7(1):3767. doi: 10.1038/s41598-017-03942-z.

2.

Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus.

Rahe MC, Murtaugh MP.

Viruses. 2017 Jun 13;9(6). pii: E148. doi: 10.3390/v9060148. Review.

3.

Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection.

Zaunders J, Xu Y, Kent SJ, Koelsch KK, Kelleher AD.

Front Immunol. 2017 May 12;8:495. doi: 10.3389/fimmu.2017.00495. eCollection 2017. Review.

4.

Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.

Cheedarla N, Precilla KL, Babu H, Vijayan KKV, Ashokkumar M, Chandrasekaran P, Kailasam N, Sundaramurthi JC, Swaminathan S, Buddolla V, Vaniambadi SK, Ramanathan VD, Hanna LE.

Sci Rep. 2017 Apr 24;7:46557. doi: 10.1038/srep46557.

5.

Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus.

Rahe MC, Murtaugh MP.

Vet Immunol Immunopathol. 2017 Apr;186:15-18. doi: 10.1016/j.vetimm.2017.02.002. Epub 2017 Feb 20. Review.

PMID:
28413045
6.

Exploring Human Antimicrobial Antibody Responses on a Single B Cell Level.

Hofmann D, Lai JR.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00544-16. doi: 10.1128/CVI.00544-16. Print 2017 May.

PMID:
28356257
7.

Role of germinal centers for the induction of broadly-reactive memory B cells.

Takahashi Y, Kelsoe G.

Curr Opin Immunol. 2017 Apr;45:119-125. doi: 10.1016/j.coi.2017.03.002. Epub 2017 Mar 27. Review.

PMID:
28355576
8.

Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.

Chuang GY, Geng H, Pancera M, Xu K, Cheng C, Acharya P, Chambers M, Druz A, Tsybovsky Y, Wanninger TG, Yang Y, Doria-Rose NA, Georgiev IS, Gorman J, Joyce MG, O'Dell S, Zhou T, McDermott AB, Mascola JR, Kwong PD.

J Virol. 2017 Apr 28;91(10). pii: e02268-16. doi: 10.1128/JVI.02268-16. Print 2017 May 15.

PMID:
28275193
9.

Investigating Substitutions in Antibody-Antigen Complexes Using Molecular Dynamics: A Case Study with Broad-spectrum, Influenza A Antibodies.

Lees WD, Stejskal L, Moss DS, Shepherd AJ.

Front Immunol. 2017 Feb 15;8:143. doi: 10.3389/fimmu.2017.00143. eCollection 2017.

10.

Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein.

Kulkarni A, Kurle S, Shete A, Ghate M, Godbole S, Madhavi V, Kent SJ, Paranjape R, Thakar M.

Front Immunol. 2017 Jan 19;8:5. doi: 10.3389/fimmu.2017.00005. eCollection 2017.

11.

Identification and specificity of broadly neutralizing antibodies against HIV.

McCoy LE, Burton DR.

Immunol Rev. 2017 Jan;275(1):11-20. doi: 10.1111/imr.12484. Review.

12.

The HIV-1 envelope glycoprotein structure: nailing down a moving target.

Ward AB, Wilson IA.

Immunol Rev. 2017 Jan;275(1):21-32. doi: 10.1111/imr.12507. Review.

PMID:
28133813
13.

Evolution of B cell analysis and Env trimer redesign.

Karlsson Hedestam GB, Guenaga J, Corcoran M, Wyatt RT.

Immunol Rev. 2017 Jan;275(1):183-202. doi: 10.1111/imr.12515. Review.

PMID:
28133805
14.

Use of broadly neutralizing antibodies for HIV-1 prevention.

Pegu A, Hessell AJ, Mascola JR, Haigwood NL.

Immunol Rev. 2017 Jan;275(1):296-312. doi: 10.1111/imr.12511. Review.

PMID:
28133803
15.

B-cell responses to HIV infection.

Moir S, Fauci AS.

Immunol Rev. 2017 Jan;275(1):33-48. doi: 10.1111/imr.12502. Review.

PMID:
28133792
16.

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.

Jaworski JP, Vendrell A, Chiavenna SM.

Front Immunol. 2017 Jan 11;7:661. doi: 10.3389/fimmu.2016.00661. eCollection 2016. Review.

17.

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.

Bruel T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, Baleux F, Bourdic K, Noël N, Lambotte O, Mouquet H, Schwartz O.

J Virol. 2017 Mar 29;91(8). pii: e02440-16. doi: 10.1128/JVI.02440-16. Print 2017 Apr 15.

PMID:
28122982
18.

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.

Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM.

Sci Immunol. 2016 Dec 16;1(6). pii: eaaj1879. doi: 10.1126/sciimmunol.aaj1879. Epub 2016 Dec 9.

19.

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.

Freund NT, Wang H, Scharf L, Nogueira L, Horwitz JA, Bar-On Y, Golijanin J, Sievers SA, Sok D, Cai H, Cesar Lorenzi JC, Halper-Stromberg A, Toth I, Piechocka-Trocha A, Gristick HB, van Gils MJ, Sanders RW, Wang LX, Seaman MS, Burton DR, Gazumyan A, Walker BD, West AP Jr, Bjorkman PJ, Nussenzweig MC.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaal2144. doi: 10.1126/scitranslmed.aal2144.

20.

Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.

Doria-Rose NA, Altae-Tran HR, Roark RS, Schmidt SD, Sutton MS, Louder MK, Chuang GY, Bailer RT, Cortez V, Kong R, McKee K, O'Dell S, Wang F, Abdool Karim SS, Binley JM, Connors M, Haynes BF, Martin MA, Montefiori DC, Morris L, Overbaugh J, Kwong PD, Mascola JR, Georgiev IS.

PLoS Pathog. 2017 Jan 4;13(1):e1006148. doi: 10.1371/journal.ppat.1006148. eCollection 2017 Jan.

Supplemental Content

Support Center